RAP 0.00% 20.5¢ resapp health limited

wow. let me get one thing straight here. FDA approval is not the...

  1. 282 Posts.
    wow. let me get one thing straight here. FDA approval is not the end point. It is only a stepping stone for us to go international. The end point here is that the whole world, USA, China, India and etc use this app for ALL respiratory diseases (not only athma) and we are sitting at $100 per share and taking dividend per quarterly. That is the end point. Maybe in 5 years?
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.